These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9359740)

  • 1. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects.
    Liu ZL; Hennessy S; Strom BL; Tsai TF; Wan CM; Tang SC; Xiang CF; Bilker WB; Pan XP; Yao YJ; Xu ZW; Halstead SB
    J Infect Dis; 1997 Nov; 176(5):1366-9. PubMed ID: 9359740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
    Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
    Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children.
    Xin YY; Ming ZG; Peng GY; Jian A; Min LH
    Am J Trop Med Hyg; 1988 Aug; 39(2):214-7. PubMed ID: 2841880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study.
    Hennessy S; Liu Z; Tsai TF; Strom BL; Wan CM; Liu HL; Wu TX; Yu HJ; Liu QM; Karabatsos N; Bilker WB; Halstead SB
    Lancet; 1996 Jun; 347(9015):1583-6. PubMed ID: 8667866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
    Kim DS; Houillon G; Jang GC; Cha SH; Choi SH; Lee J; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Kim HS; Bang J; Naimi Z; Bosch-Castells V; Boaz M; Bouckenooghe A
    Hum Vaccin Immunother; 2014; 10(9):2656-63. PubMed ID: 25483480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.
    Chotpitayasunondh T; Sohn YM; Yoksan S; Min J; Ohrr H
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S195-203. PubMed ID: 22043776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against Japanese encephalitis by inactivated vaccines.
    Hoke CH; Nisalak A; Sangawhipa N; Jatanasen S; Laorakapongse T; Innis BL; Kotchasenee S; Gingrich JB; Latendresse J; Fukai K
    N Engl J Med; 1988 Sep; 319(10):608-14. PubMed ID: 2842677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
    Yu Y
    Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD; Firestone CY; Whitehead SS
    J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.
    Eckels KH; Yu YX; Dubois DR; Marchette NJ; Trent DW; Johnson AJ
    Vaccine; 1988 Dec; 6(6):513-8. PubMed ID: 3149829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
    Liu X; Zhao D; Jia L; Xu H; Na R; Ge Y; Liu S; Yu Y; Li Y
    Vaccine; 2018 Jul; 36(31):4650-4656. PubMed ID: 29954631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.
    Feroldi E; Pancharoen C; Kosalaraksa P; Chokephaibulkit K; Boaz M; Meric C; Hutagalung Y; Bouckenooghe A
    Pediatr Infect Dis J; 2014 Jun; 33(6):643-9. PubMed ID: 24717964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: Probable association of mutation in amino acid of its envelope protein.
    Nath B; Gupta A; Khan SA; Kumar S
    Microb Pathog; 2017 Oct; 111():187-192. PubMed ID: 28867626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?
    Choi UY; Lee SY; Kim KH; Kim DS; Choi KM; Cha SH; Kang JH
    J Trop Pediatr; 2013 Oct; 59(5):423-5. PubMed ID: 23764540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
    Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
    Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.
    Sricharoenchai S; Lapphra K; Chuenkitmongkol S; Phongsamart W; Bouckenooghe A; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
    Pediatr Infect Dis J; 2017 Feb; 36(2):e45-e47. PubMed ID: 27846060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.
    Yun KW; Lee HJ; Park JY; Cho HK; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
    Vaccine; 2018 Mar; 36(11):1398-1404. PubMed ID: 29429815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Observations on the reactions following vaccination of the inactivated Japanese encephalitis virus vaccine from tissue culture (author's transl)].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Mar; 15(2):98-100. PubMed ID: 7307821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.